Menu

Zika and Birth Defects

A study provides stronger evidence for the causal link between Zika infection and microcephaly, and warns of a host of other birth defects associated with the virus.

Mar 8, 2016
Catherine Offord

A baby with microcephaly (left) compared to a baby with a typical-sized head (right)WIKIMEDIA, CDCMore than one-quarter of women taking part in a study of Zika infection during pregnancy had fetuses with potentially serious abnormalities, according to a report published last week (March 4) in the New England Journal of Medicine. The analysis compared fetuses in infected mothers to fetuses in non-infected mothers, thereby providing the control-like group that many previous studies have lacked.

The analysis is “what people have been waiting for,” Amesh Adalja of the University of Pittsburgh Medical Center, who was not involved in the work, told LiveScience, adding that the comparison of the two groups allowed stronger links to be drawn between Zika infection and microcephaly. “This is the closest we’ve gotten to [proving] causation. . . . For all intents and purposes, this justifies the concern raised early on.”

Of the 88 women enrolled in the study, 72 tested positive for Zika virus infection. While examination of the fetuses of all Zika-negative women found no defects, examinations of the fetuses in 42 Zika-infected women revealed abnormalities in 12, including central nervous system lesions (seven fetuses) and growth restriction with or without microcephaly (five fetuses). Two of the fetuses in Zika-infected women died at 36 and 38 weeks of gestation.

“We saw a very high percentage of abnormal fetal ultrasounds, and we saw a significant number of central nervous system findings, which is surprising to us,” study coauthor Karin Nielsen-Saines of the University of California, Los Angeles, told STAT News. “This alerts people that pregnancy in women affected with Zika are high-risk pregnancies.”

Catherine Spong of the National Institute of Child Health and Human Development, who was not involved with the study, told STAT that the results are important and concerning, but also noted that the sample sizes were small. “Stillbirth has many, many different causes, including maternal age [and] genetic factors,” she said.

The researchers suggested using the term “congenital Zika virus syndrome” to reflect the host of birth abnormalities now being linked to infection, Nielson-Saines told LiveScience. “Zika definitely causes the problems,” she said. “We think microcephaly is only the tip of the iceberg.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!